You are here

Bioartificial Brain Slices for Drug Screening

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43MH099721-01A1
Agency Tracking Number: R43MH099721
Amount: $599,889.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIMH
Solicitation Number: PA11-133
Timeline
Solicitation Year: 2013
Award Year: 2013
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
185 ALLEN BROOK LN, STE 201
WILLISTON, VT -
United States
DUNS: 787008242
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 PAUL ANGSTMAN
 (802) 288-9290
 paul@mbfbioscience.com
Business Contact
 JACOB GLASER
Phone: (802) 288-9290
Email: jack@mbfbioscience.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): It has become evident that the microvasculature (i.e., the vasculature visible at the light microscopic level) plays a critical role in the plasticity of he brain under various physiological and pathological conditions,including fundamental processes in neuroplasticity such as axonal, dendritic and synaptic plasticity during brain development, learning, recovery from traumatic brain injury and brain inflammation, aging and neurodegeneration, as well as during neurogenesis (i.e., the generation of new neurons) and the migration of neuronal precursors (to their final destination in the brain). Accordingly, investigators have attempted for more than 30 years to trace, reconstruct, visualize and quantitatively characterize the microscopic three-dimensional (3D) micro-angioarchitecture of the brain in normal and pathological tissue (3D microangioarchitectonics). However, there has been very little use of 3D microangioarchitectonics in neuroscience research. This is due to thepaucity of tools to study 3D microangioarchitectonics. We therefore propose to create Vesselucida, an innovative software product to perform advanced, interactive and automatic 3D microangioarchitectonics in normal and pathological brain tissue. This system will allow significant advancements in studies addressing the roles of microvessels on various aspects of neuroplasticity in neuroscience research, as well as in pharmacological and biotechnology research and development as the basis for the developmentof innovative treatments to fight complex brain diseases. Accordingly, the development of Vesselucida represents clear progress beyond the state-of-the-art, with great benefits for the neuroscience research community and society in general. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The proposed project will enable important new research, which is currently not feasible, into the critical role of the microvasculature in the plasticity o the brain under various physiological and pathologicalconditions (such as brain development, learning, recovery from traumatic brain injury and brain inflammation, aging and neurodegeneration). To achieve this aim, the proposed project will develop and commercialize an innovative image analysis system to permit interactive and automatic reconstruction of the blood vessel network in normal and pathological brain tissue at the light microscopic level. This system will open new horizons in studies addressing the roles of microvessels on various aspects of neuroplasticity in neuroscience research, as well as in pharmacological and biotechnology research and development as the basis for the development of innovative treatments to fight complex brain diseases.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government